Shared regulatory elements in the promoters of MHC class I and class II genes

Immunology Today

Volumn 19, Issue 7, 1998, Pages 308-312

  Van Den Elsen, Peter J ^a   Peijnenburg, Ad ^a   Van Eggermond, Marja C j a ^a   Gobin, Sam J p ^a  

^a Division of Molecular Biology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN CIITA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0032126250     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(98)01287-0     Document Type: Article

References (34)

1. Mach B., Steimle V., Martinez-Soria E., Reith W. Annu. Rev. Immunol. 14:1996;301-331.
2. Louis-Plence P., Moreno C.S., Boss J.M. J. Immunol. 159:1997;3899-3909.
3. Le Bouteiller P. Crit. Rev. Immunol. 14:1994;89-129.
4. Steimle V., Otten L.A., Zufferey M., Mach B. Cell. 75:1993;135-146.
5. Steimle V., Durand B., Barras E.et al. Genes Dev. 9:1995;1021-1032.
6. Durand B., Sperisen P., Emery P.et al. EMBO J. 16:1997;1045-1055.
7. Moreno C.S., Rogers E.M., Brown J.A., Boss J.M. J. Immunol. 158:1997;5841-5848.
8. Lisowska-Grospierre, B., Charron, D., De Préval, C. et al. (1984) in Histocompatibility Testing (Albert, E.D. et al., eds), pp. 650-655, Springer-Verlag.
9. Lambert M., Van Eggermond M., Andrien M.et al. Res. Immunol. 142:1991;789-798.
10. Lambert M., Van Eggermond M., Verheij C., Van Ree J., Van den Elsen P.J. Immunodeficiency. 4:1993;277-284.
11. Lisowska-Grospierre B., Fondaneche M-C., Rols M-P., Griscelli C., Fischer A. Hum. Mol. Genet. 3:1994;953-958.
12. Sabatier C., Gimenez C., Calin-Laurens V., Rabourdin-Combe C., Touraine J-L. C. R. Acad. Sci. 319:1996;789-798.
13. Peijnenburg A., Godthelp B., Van Boxel-Dezaire A., Van den Elsen P. Immunogenetics. 41:1995;287-294.
14. Gobin S.J.P., Peijnenburg A., Keijsers V., Van den Elsen P. Immunity. 6:1997;601-611.
15. Martin B.K., Chin K-C., Olsen J.C.et al. Immunity. 6:1997;591-600.
16. Hasegawa S., Boss J. Nucleic Acids Res. 22:1991;6269-6276.
17. Moreno C., Emery P., West J.E.et al. J. Immunol. 155:1995;4313-4321.
18. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J. Immunity. 2:1995;533-543.
19. Zhou H., Glimcher L.H. Immunity. 2:1995;545-553.
20. Scholl T., Mahanta S.K., Strominger J.L. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6330-6334.
21. Wright K.L., Vilen B.J., Itoh-Lindstrom Y.et al. EMBO J. 13:1994;4042-4053.
22. Reith W., Siegrist C-A., Durand B., Barras E., Mach B. Proc. Natl. Acad. Sci. U. S. A. 91:1994;554-558.
23. Kara C.J., Glimcher L.H. Immunogenetics. 37:1993;227-230.
24. Ono H., Figueroa F., O'hUigin C., Klein J. Immunogenetics. 38:1993;1-10.
25. Kroemer G., Zoorab R., Auffray C. Immunogenetics. 31:1990;405-409.
26. Vallejo A., Pease L. J. Immunol. 154:1995;3912-3921.
27. Chin K-C., Mao C., Skinner C.et al. Immunity. 1:1994;687-697.
28. Chang C-H., Flavell R.A. J. Exp. Med. 181:1995;765-767.
29. Kern I., Steimle V., Siegrist C-A., Mach B. Int. Immunol. 7:1995;1295-1299.
30. Riegert P., Anderson R., Bumstead N.et al. Proc. Natl. Acad. Sci. U. S. A. 93:1996;1243-1248.
31. Villard J., Lisowska-Grosspierre B., Van den Elsen P.J., Fischer A., Reith W., Mach B. New Engl. J. Med. 337:1997;748-753.
32. Dey A., Thornton A.M., Lonergan M., Weissman S.M., Chamberlain J.W., Ozato K. Mol. Cell. Biol. 12:1992;3590-3599.
33. Gobin, S.J.P., Keijsers, V., Woltman, A.M., Peijnenburg, A., Wilson, L. and Van den Elsen, P.J. (1997) in Genetic Diversity of HLA: Functional and Medical Implications (Vol. 2) (Charron, D., ed.), pp. 295-297, Medical and Scientific International Publisher.
34. Flajnik M.F., Canel C., Kramer J., Kasahara M. Immunogenetics. 33:1991;295-300.